Tag Archives: RXII

Top Blue Chip Stocks For 2021

Wall Street analysts predict that Boardwalk Pipeline Partners, LP (NYSE:BWP) will post $316.93 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Boardwalk Pipeline Partners’ earnings. The highest sales estimate is $320.30 million and the lowest is $312.88 million. Boardwalk Pipeline Partners reported sales of $317.60 million in the same quarter last year, which would indicate a negative year over year growth rate of 0.2%. The company is scheduled to report its next quarterly earnings results on Monday, July 30th.

On average, analysts expect that Boardwalk Pipeline Partners will report full year sales of $1.31 billion for the current financial year, with estimates ranging from $1.30 billion to $1.31 billion. For the next fiscal year, analysts anticipate that the firm will report sales of $1.31 billion per share, with estimates ranging from $1.22 billion to $1.40 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow Boardwalk Pipeline Partners.

Top Blue Chip Stocks For 2021: Empire State Realty Trust, Inc.(ESRT)

We are a self-administered and self-managed real estate investment trust, or REIT, that owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area, including the Empire State Building, the world’s most famous building. As of December 31, 2015, our total portfolio, containing 10.1 million rentable square feet of office and retail space, was 87.3% occupied. Including signed leases not yet commenced, our total portfolio was 89.1% leased. As of December 31, 2015, we owned 14 office properties (including three long-term ground leasehold interests) encompassing approximately 9.3 million rentable square feet of office space, which were approximately 86.7% occupied or 88.6% leased including signed leases not yet commenced. Nine of these properties are located in the midtown Manhattan market and encompass approximately 7.5 million rentable square feet of office space, including the Empire State Building.   Advisors’ Opinion:

  • [By Matthew Frankel, CFP]

    With all of that in mind, here’s why I think Realty Income (NYSE:O) and Empire State Realty Trust (NYSE:ESRT) make excellent IRA investments. In fact, I hold both in my retirement portfolio.

  • [By Logan Wallace]

    Citadel Advisors LLC grew its holdings in Empire State Realty Trust Inc (NYSE:ESRT) by 109.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,444,342 shares of the real estate investment trust’s stock after purchasing an additional 1,801,601 shares during the quarter. Citadel Advisors LLC’s holdings in Empire State Realty Trust were worth $58,899,000 at the end of the most recent reporting period.

Top Blue Chip Stocks For 2021: RXI Pharmaceuticals Corporation(RXII)

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents. Its clinical development programs include RXI-109, a self-delivering RNAi compound, which is in Phase IIa clinical trial that is used to prevent or reduce dermal scarring following surgery or trauma, as well as for the management of hypertrophic scars and keloids; and Samcyprone, an immunomodulation agent, which is in Phase IIa clinical trial for the treatment of various disorders, such as alopecia areata, warts, and cutaneous metastases of melanoma. The companys preclinical program includes the development of products for ocular indications with RXI-109, including retinal and corneal scarring. Its discovery stage development programs include a dermatology franchise for the discovery of collagenase and tyrosinase targets for its RNAi platform; and ophthalmology franchise, a program for the discovery of sd-rxRNA compounds for oncology indications, including retinoblastoma. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get RXi Pharmaceuticals alerts:

    Intercellular Adhesion Molecule 1 Market Pipeline Review H1 Products in Clinical Stage, Methodology, therapeutic … (talkinvestor.com) Hypoxia Inducible Factor 1 Alpha Market Research Report H1: Drug Profile, Top Industry Intelligence and Therapeutic … (thestockanalysis.com) Connective Tissue Growth Factor Market Opportunities, Demands, Size, Share, Trends, Industry Sales Area and Its … (trueindustrynews.com) Global Connective Tissue Growth Factor Market 2018 Manufacturing Analysis and Development Forecast 2025 (trueindustrynews.com) Zacks: Analysts Expect RXi Pharmaceuticals Corp (RXII) to Announce -$0.56 EPS (americanbankingnews.com)

    Shares of RXi Pharmaceuticals stock traded down $0.04 on Tuesday, hitting $1.92. The company had a trading volume of 27,600 shares, compared to its average volume of 258,173. The stock has a market capitalization of $8.21 million, a PE ratio of -0.46 and a beta of 1.20. RXi Pharmaceuticals has a 52 week low of $1.90 and a 52 week high of $7.70.

  • [By Shane Hupp]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get RXi Pharmaceuticals alerts:

    New Research Study on Connective Tissue Growth Factor Market 2018 to 2025 (morningoutlook.com) Hypoxia Inducible Factor 1 Alpha Market Pipeline Therapeutics H1, 2018 Product Description, Mechanism of Action … (exclusiveherald.com) Human Papillomavirus Associated Diseases Market Pipeline Therapeutics 2018 Drug Description, Target Finding, and … (thefreenewsman.com) Warts Market Therapeutic Pipeline H1, Drugs, Diagnostics, Vaccines and Preventive Technologies (newspublicist.com) Brokerages Anticipate RXi Pharmaceuticals Corp (RXII) to Post -$0.56 Earnings Per Share (americanbankingnews.com)

    Shares of RXi Pharmaceuticals traded down $0.01, hitting $2.24, on Tuesday, MarketBeat Ratings reports. 55,400 shares of the stock were exchanged, compared to its average volume of 275,015. The company has a market capitalization of $9.96 million, a price-to-earnings ratio of -0.53 and a beta of 1.15. RXi Pharmaceuticals has a one year low of $1.90 and a one year high of $7.70.

Top Blue Chip Stocks For 2021: First Industrial Realty Trust, Inc.(FR)

First Industrial Realty Trust, Inc. is a Maryland corporation organized on August 10, 1993, and is a real estate investment trust (“REIT”) as defined in the Internal Revenue Code of 1986 (the “Code”). We are a self-administered and fully integrated real estate company which owns, manages, acquires, sells, develops, and redevelops industrial real estate. As of December 31, 2015, our in-service portfolio consisted of 234 light industrial properties, 78 R&D/flex properties, 167 bulk warehouse properties and 101 regional warehouse properties containing an aggregate of approximately 61.6 million square feet of gross leasable area (“GLA”) located in 25 states. Our in-service portfolio includes all properties other than developed, redeveloped and acquired properties that have not yet reached stabilized occupancy (generally defined as properties that are 90% leased). We began operations on July 1, 1994.   Advisors’ Opinion:

  • [By Max Byerly]

    Research analysts at B. Riley started coverage on shares of First Majestic Silver (NYSE:AG) (TSE:FR) in a research report issued to clients and investors on Friday. The brokerage set a “neutral” rating and a $6.00 price target on the mining company’s stock. B. Riley’s price objective points to a potential downside of 10.98% from the stock’s previous close.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on First Industrial Realty Trust (FR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    First Industrial Realty Trust, Inc. (NYSE:FR) declared a quarterly dividend on Tuesday, August 7th, Zacks reports. Shareholders of record on Friday, September 28th will be given a dividend of 0.218 per share by the real estate investment trust on Monday, October 15th. This represents a $0.87 annualized dividend and a dividend yield of 2.74%. The ex-dividend date is Thursday, September 27th.

  • [By Joseph Griffin]

    First Majestic Silver Corp. (NYSE:AG) (TSE:FR)’s share price gapped down prior to trading on Friday . The stock had previously closed at $5.88, but opened at $5.73. First Majestic Silver shares last traded at $5.70, with a volume of 4362990 shares traded.

Top Blue Chip Stocks For 2021: TE Connectivity Ltd.(TEL)

TE Connectivity Ltd. provides engineered electronic components, network solutions, specialty products, and subsea telecommunication systems. Its Electronic Components segment supplies passive electronic components, which include connectors and interconnect systems, relays, switches, sensors, and wire and cable to original equipment manufacturers and their contract manufacturers in the automotive, data communications, industrial, appliance, computer, and consumer devices markets. The company?s Network Solutions segment supplies infrastructure components and systems for telecommunications and energy markets. This segment provides components comprising connectors, above- and below-ground enclosures, heat shrink tubing, cable accessories, surge arrestors, fiber optic cabling, copper cabling, and racks for copper and fiber networks; electronic systems for test access and intelligent cross-connect applications; and integrated cabling solutions for cabling and building management . This segment also sells insulators, power measurement products, CATV accessories, network interface devices, raceway systems, and duct accessories. Its Specialty Products segment offers engineered custom solutions, components, and connectors for electronic systems, subsystems, and devices in the aerospace, defense, and marine; touch systems; medical; and circuit protection markets. The company?s Subsea Communications segment designs, builds, maintains, and tests undersea fiber optic networks for the telecommunications, and oil and gas markets. It sells its products in the Americas, Europe/the Middle East/Africa, and the Asia-Pacific. The company was formerly known as Tyco Electronics Ltd. and changed its name to TE Connectivity Ltd. on March 10, 2011. TE Connectivity Ltd. was founded in 1941 and is based in Schaffhausen, Switzerland.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on TE Connectivity (TEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    TE Connectivity (NYSE:TEL) had its price target dropped by Morgan Stanley from $116.00 to $107.00 in a research note issued on Monday, Stock Target Advisor reports. The brokerage currently has an “overweight” rating on the electronics maker’s stock. Morgan Stanley’s price target points to a potential upside of 16.46% from the company’s previous close.

Hot Blue Chip Stocks To Own For 2019

They’ve each crafted massive consumer-facing businesses that, over the decades, have delivered awesome returns for long-term shareholders. However, both Procter & Gamble and Pepsi are struggling with market share losses today that have caused Wall Street to turn more pessimistic about their growth outlooks.

The good news is that this sour mood has pushed dividend yields to nearly 4% for these blue chip stocks. But which one might make the better investment today? Let’s take a closer look.

P&G vs. Pepsi

Company Market Cap Sales Growth Operating Profit Margin Dividend Yield
Procter & Gamble (NYSE:PG) $183 billion 2% 15.7% 3.9%
PepsiCo (NASDAQ:PEP) $137 billion 2% 16.5% 3.8%

Data sources: Company financial filings. Sales growth excludes acquisitions and divestments and is on a constant-currency basis for the past complete fiscal year.

Hot Blue Chip Stocks To Own For 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of Antares Pharma (NASDAQ:ATRS) were up 11.8% at 3:12 p.m. EDT on Monday after the company announced a deal with Pfizer (NYSE:PFE) to develop a combination drug-device rescue pen.

  • [By Max Byerly]

    Antares Pharma (NASDAQ:ATRS) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Friday.

  • [By Ethan Ryder]

    Antares Pharma (NASDAQ:ATRS) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Shane Hupp]

    HC Wainwright set a $5.00 price objective on Antares Pharma (NASDAQ:ATRS) in a research report released on Friday. The brokerage currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By ]

    Antares Pharma (Nasdaq: ATRS), the smallest company in the top five, is a specialty pharmaceutical company developing and manufacturing proprietary delivery technology methods (such as self-injection systems for its partner pharmaceutical and biotech companies). This company’s expected growth makes it potentially attractive in terms of valuation, although ATRS depends on its partner companies for much of its future potential.

Hot Blue Chip Stocks To Own For 2019: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    Investors looking for growth should still like AbbVie despite its Rova-T challenges. Income-seeking investors have just as much to like. AbbVie’s dividend yield currently stands just a notch below 4%. The company has increased its dividend payout by a whopping 140% since it was spun off from parent Abbott Labs (NYSE:ABT) in 2013.

  • [By Stephan Byrd]

    Summit Securities Group LLC purchased a new stake in shares of Abbott Laboratories (NYSE:ABT) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 57,500 shares of the healthcare product maker’s stock, valued at approximately $3,507,000. Abbott Laboratories makes up about 0.5% of Summit Securities Group LLC’s investment portfolio, making the stock its 22nd largest position.

  • [By Stephan Byrd]

    Schwab Charles Investment Management Inc. reduced its position in Abbott Laboratories (NYSE:ABT) by 4.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,028,813 shares of the healthcare product maker’s stock after selling 298,676 shares during the period. Schwab Charles Investment Management Inc. owned 0.40% of Abbott Laboratories worth $428,688,000 at the end of the most recent quarter.

  • [By ]

    Drug companies Eli Lilly (LLY) gained about 2%, Pfizer (PFE) added 1.3%, Abbott Laboratories (ABT) rose 1.2% and Bristol-Myers Squibb (BMY) advanced by 1.4% after the president promised lower list prices, less costs for patients and more competition among the drug makers.

Hot Blue Chip Stocks To Own For 2019: Credit Suisse Asset Management Income Fund, Inc.(CIK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Credit Suisse AM Inc Fund Inc. (NYSEAMERICAN:CIK) announced a monthly dividend on Wednesday, June 27th, Wall Street Journal reports. Investors of record on Wednesday, July 11th will be given a dividend of 0.0225 per share on Tuesday, July 17th. This represents a $0.27 annualized dividend and a yield of 8.57%. The ex-dividend date of this dividend is Tuesday, July 10th. This is an increase from Credit Suisse AM Inc Fund’s previous monthly dividend of $0.02.

Hot Blue Chip Stocks To Own For 2019: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get RXi Pharmaceuticals alerts:

    New Research Study on Connective Tissue Growth Factor Market 2018 to 2025 (morningoutlook.com) Hypoxia Inducible Factor 1 Alpha Market Pipeline Therapeutics H1, 2018 Product Description, Mechanism of Action … (exclusiveherald.com) Human Papillomavirus Associated Diseases Market Pipeline Therapeutics 2018 Drug Description, Target Finding, and … (thefreenewsman.com) Warts Market Therapeutic Pipeline H1, Drugs, Diagnostics, Vaccines and Preventive Technologies (newspublicist.com) Brokerages Anticipate RXi Pharmaceuticals Corp (RXII) to Post -$0.56 Earnings Per Share (americanbankingnews.com)

    Shares of RXi Pharmaceuticals traded down $0.01, hitting $2.24, on Tuesday, MarketBeat Ratings reports. 55,400 shares of the stock were exchanged, compared to its average volume of 275,015. The company has a market capitalization of $9.96 million, a price-to-earnings ratio of -0.53 and a beta of 1.15. RXi Pharmaceuticals has a one year low of $1.90 and a one year high of $7.70.

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get RXi Pharmaceuticals alerts:

    Intercellular Adhesion Molecule 1 Market Pipeline Review H1 Products in Clinical Stage, Methodology, therapeutic … (talkinvestor.com) Hypoxia Inducible Factor 1 Alpha Market Research Report H1: Drug Profile, Top Industry Intelligence and Therapeutic … (thestockanalysis.com) Connective Tissue Growth Factor Market Opportunities, Demands, Size, Share, Trends, Industry Sales Area and Its … (trueindustrynews.com) Global Connective Tissue Growth Factor Market 2018 – Manufacturing Analysis and Development Forecast 2025 (trueindustrynews.com) Zacks: Analysts Expect RXi Pharmaceuticals Corp (RXII) to Announce -$0.56 EPS (americanbankingnews.com)

    Shares of RXi Pharmaceuticals stock traded down $0.04 on Tuesday, hitting $1.92. The company had a trading volume of 27,600 shares, compared to its average volume of 258,173. The stock has a market capitalization of $8.21 million, a PE ratio of -0.46 and a beta of 1.20. RXi Pharmaceuticals has a 52 week low of $1.90 and a 52 week high of $7.70.

Hot Blue Chip Stocks To Own For 2019: Home Bancorp, Inc.(HBCP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Home Bancorp (HBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Home Bancorp (HBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Beneficial Bancorp (NASDAQ: BNCL) and Home Bancorp (NASDAQ:HBCP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Home Bancorp (HBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Media stories about Home Bancorp (NASDAQ:HBCP) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Home Bancorp earned a news impact score of 0.02 on Accern’s scale. Accern also gave press coverage about the bank an impact score of 47.6769620242767 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Hot Blue Chip Stocks To Own For 2019: Intuit Inc.(INTU)

Advisors’ Opinion:

  • [By Wayne Duggan]

    With bitcoin prices now at their highest levels since March at above $9,200, former Intuit Inc. (NASDAQ: INTU) and Paypal Holdings Inc (NASDAQ: PYPL) CEO Bill Harris wrote an op-ed piece for Recode in which he called bitcoin “the greatest scam in history.” Harris said cryptocurrencies are massive pump-and-dump schemes and fraud artists are taking advantage of cryptocurrency investors naivety and greed. He added that bitcoin has no intrinsic value, isn't an effective store of value and isn't accepted by the vast majority of businesses, making it virtually useless as a means of payment.

  • [By Daniel Sparks]

    With the big news that Intuit’s (NASDAQ:INTU) CEO and CTO are both stepping down at the end of the year, it’s easy to overlook the company’s fourth-quarter results. As the two executives get ready to head out the door, Intuit posted expectation-crushing numbers, including strong double-digit growth in both its small-business and self-employed segment and its consumer segment.

  • [By Daniel Sparks]

    Financial software specialist Intuit (NASDAQ:INTU) reports fiscal 2018 fourth-quarter results later this month.

    Expectations for the period are high. Setting the stage for an impressive finish to fiscal 2018, management gave its revenue guidance for the year a significant boost. And adding further pressure for a good fiscal fourth quarter is the fact that shares of Intuit have risen 54% in the past twelve months and 34% year to date, crushing the overall market’s returns.

  • [By Matt Krantz]

    Most brokerage firms will allow you to access papers online. Not only is that tidier, but it’s also more secure. Also, software like Quicken and online services like Personal Capital and Intuit’s (NASDAQ:INTU) Mint are much better than paper at pulling together all of your accounts, so you can see how much you have.

  • [By Lee Jackson]

    Intuit Inc. (NASDAQ: INTU) has been on a roll this year and hits all the metrics in the technology sector for accounting needs. The company is a provider of business and financial management solutions for small and medium-sized businesses, financial institutions, consumers and accounting professionals. Products and services include TurboTax, QuickBooks, Quicken, small business financial management and payroll processing, personal finance and tax preparation and filing and online banking services through its Digital Insight acquisition. Intuit also offers products on a software as a service (SaaS) platform across all its business divisions.

Hot Low Price Stocks To Invest In 2019

Make way for some waves. CVS Health (CVS) and Express Scripts (ESRX) have released their formulary exclusion list for 2017, which details which prescription drugs will not be covered by health plans.

Why do we care? Commercial payors have been showing signs of pushing back against high drugs costs, which is a huge concern for drug companies and their investors. The coverage list determines whether millions of privately insured individuals can easily use an insurance co-payment to buy their prescriptions. If a drug is excluded, it can dramatically hobble sales.

Thus, the formulary exclusion lists can be used as a tool by insurers and PBMs leverage you might say to negotiate with drug makers for better prices. Its also a double edged sword that can cost a PBM customers.

Express Scripts says it will save customers $1.8 billion in 2017 by excluding a list of 85 drugs from its formulary in 2017. It added a handful of new names to the list, including Bristol-Myers Squibb‘s (BMY) arthritis medication Orencia, Eli Lilly‘s (LLY) new psoriasis medication and Valeants (VRX) Zyclara, an actinic keratosis skin cream, while also removing several names, including Pfizer‘s (PFE) arthritis drugs Xeljanz (it is now a preferred alternative follow price negotiations with Express Scripts).

Hot Low Price Stocks To Invest In 2019: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    ConocoPhillips (NYSE:COP) worked hard to turn its business around during the oil market downturn. We saw the first glimpse of its ability to thrive, now that prices are on the upswing, at the end of last year when the U.S. oil giant reported $545 million, or $0.45 per share, of adjusted earnings. That result marked a significant improvement from the loss it had posted in the previous year.

  • [By Chris Lange]

    The number of ConocoPhillips (NYSE: COP) shares short dropped to 17.34 million from the previous level of 18.27 million. Shares were trading at $68.71, within a 52-week range of $42.27 to $71.71.

  • [By Chris Lange]

    The number of ConocoPhillips (NYSE: COP) shares short dropped to 18.27 million from the previous level of 21.33 million. Shares were trading at $70.01 within a 52-week range of $42.27 to $71.71.

  • [By Matthew DiLallo]

    Oil prices have been on fire over the past year and recently topped $70 a barrel, which is the highest crude has been since late 2014. That rally in the oil market has helped fuel big-time gains in many oil stocks. Three that stand out are Anadarko Petroleum (NYSE:APC), Hess (NYSE:HES), and ConocoPhillips (NYSE:COP) because each has risen more than 20% this year. They might still have additional upside from here given that all three plan on spending billions of dollars to buy back more of their stock.

  • [By Garrett Baldwin]

    Eight Seconds… $1,260 Richer: Words can’t describe what you’ll see in this shocking footage – because you’ll witness, live on camera, one man become $4,238 richer with just three clicks of a mouse. And if you follow the simple instructions in this video, you’ll learn how to set yourself up for an instant $2,918 payday opportunity. You need to see this to believe it…

    Three Stocks to Watch Today: COP, HD, HSBC
    ConocoPhillips (NYSE: COP) has seized assets from the Venezuelan-owned firm PDVSA in the Caribbean. The company won a court case that will allow it to take over assets owned by the Venezuelan government. The court enabled the seizures as part of a broader plan to allow the firm to recoup roughly $2 billion following the 2007 nationalization of its assets in Venezuela by the huge Castro-led government.
    Monday will be a quiet day on the earnings front. Investors are looking to Tuesday’s calendar, when The Home Depot Inc. (NYSE: HD) reports earnings. Tomorrow, Wall Street analysts expect that Home Depot will report earnings per share of $2.07 on top of $25.2 billion in revenue. Investors will be hoping that the company reports strong profits thanks to an improving U.S. economy and the recent tax reform law.
    Expect a lot of chatter today about blockchain technology. That’s because ING Bank and HSBC Holdings Plc.(NYSE: HSBC) announced over the weekend that they engaged in their first trade ever using blockchain technology. The two engaged in a trade on behalf of Cargill to finance a shipment of soybeans from Argentina to Malaysia.
    Today, look for earnings reports from Agilent Technologies (NYSE: A), Itron Inc.(Nasdaq: ITRI), Vipshop Holdings Ltd.(Nasdaq: VIPS), Amyris Biotechnologies Inc. (Nasdaq: AMRS), Sky Solar Holdings Ltd.(Nasdaq: SKYS), Mazor Robotics Ltd.(Nasdaq: MZOR), China Lodging Group Ltd. (Nasdaq: HTHT), and Mimecast Ltd.(Nasdaq: MIME).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

  • [By Ethan Ryder]

    Whittier Trust Co. grew its holdings in ConocoPhillips (NYSE:COP) by 15.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 11,978 shares of the energy producer’s stock after acquiring an additional 1,635 shares during the period. Whittier Trust Co.’s holdings in ConocoPhillips were worth $710,000 at the end of the most recent reporting period.

Hot Low Price Stocks To Invest In 2019: A V Homes, Inc.(AVHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Evan Niu, CFA]

    Shares of AV Homes (NASDAQ:AVHI) have soared today, up by 29% as of 1:40 p.m. EDT, after the company announcedit was being acquired. Larger homebuilder Taylor Morrison Home Corporation (NYSE:TMHC) is scooping up AV Homes in a $1 billion deal.

Hot Low Price Stocks To Invest In 2019: Blackrock Health Sciences Trust(BME)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of B&M European Value Retail SA (LON:BME) have earned an average recommendation of “Buy” from the sixteen ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 442.92 ($5.90).

  • [By Max Byerly]

    B&M European Value Retail (LON:BME) had its target price boosted by analysts at HSBC from GBX 470 ($6.26) to GBX 500 ($6.66) in a report released on Wednesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.54% from the company’s current price.

Hot Low Price Stocks To Invest In 2019: Bazaarvoice, Inc.(BV)

Advisors’ Opinion:

  • [By Paul Ausick]

    BrightView Holdings Inc. (NYSE: BV) raised $469 million selling 21.3 million shares at $22, the low end of the expected range. Shares dropped 3% on the first day of trading and closed the week flat.

  • [By Paul Ausick]

    Below is Renaissance Capital’s list of the second quarter’s 10 largest IPOs ranked by deal size. We’ve also included the stock’s first-day pop (or decline) and its return as of the most recent close. Spotify Technology S.A. (NYSE: SPOT) is not included because its IPO was a direct offering that did not raise any new cash. Spotify shares popped nearly 13% on the April offering date, and the return to date is 27%.

    AXA Equitable Holdings Inc. (NYSE: EQH): $2.75 billion; first-day pop of 1.7%; return to date: 1.3% GreenSky LLC (NASDAQ: GSKY): $874 million: pop of 1.6%; return of 7.9% BJ’s Wholesale Club Holdings Inc. (NYSE: BJ): $638 million; pop and return of 29.4% DocuSign Inc. (NASDAQ: DOCU): $629 million; pop of 37.0%; return of 83.0% Pivotal Software Inc. (NYSE: PVTL): $555 million; pop of 5.0%; return of 71.0% GrafTech International Ltd. (NYSE: EAF): $525 million; decline of 3.7%; return of 23.0% BrightView Holdings Inc. (NYSE: BV): $469 million; decline of 2.7%; return of 2.7% Ceridian HCM Holding Inc. (NYSE: CDAY): $462 million; pop of 42.0%; return of 55.0% Essential Properties Realty Trust Inc. (NYSE: EPRT): $455 million; decline of 2.6%; return of 3.6% PluralSight Inc. (NASDAQ: PS): $311 million; pop of 33.0%; return of 61.0%

    Looking ahead to the third quarter, Renaissance Capital notes 65 companies currently in the IPO pipeline looking to raise $11 billion. Real estate firm Cushman & Wakefield is the both the largest potential IPO ($500 million) and the largest based on trailing 12-month sales ($7.23 billion). The pipeline is again heavy on health care offerings (11), industrials (five), financials (five) and, in a bit of a comeback, energy (four).

  • [By Chris Lange]

    BrightView Holdings Inc. (NYSE: BV) entered the market quietly in its initial public offering (IPO). The stock initially saw a slight gain compared to the announced pricing but quickly fell flat.

Hot Low Price Stocks To Invest In 2019: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get RXi Pharmaceuticals alerts:

    Intercellular Adhesion Molecule 1 Market Pipeline Review H1 Products in Clinical Stage, Methodology, therapeutic … (talkinvestor.com) Hypoxia Inducible Factor 1 Alpha Market Research Report H1: Drug Profile, Top Industry Intelligence and Therapeutic … (thestockanalysis.com) Connective Tissue Growth Factor Market Opportunities, Demands, Size, Share, Trends, Industry Sales Area and Its … (trueindustrynews.com) Global Connective Tissue Growth Factor Market 2018 Manufacturing Analysis and Development Forecast 2025 (trueindustrynews.com) Zacks: Analysts Expect RXi Pharmaceuticals Corp (RXII) to Announce -$0.56 EPS (americanbankingnews.com)

    Shares of RXi Pharmaceuticals stock traded down $0.04 on Tuesday, hitting $1.92. The company had a trading volume of 27,600 shares, compared to its average volume of 258,173. The stock has a market capitalization of $8.21 million, a PE ratio of -0.46 and a beta of 1.20. RXi Pharmaceuticals has a 52 week low of $1.90 and a 52 week high of $7.70.

  • [By Shane Hupp]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get RXi Pharmaceuticals alerts:

    New Research Study on Connective Tissue Growth Factor Market 2018 to 2025 (morningoutlook.com) Hypoxia Inducible Factor 1 Alpha Market Pipeline Therapeutics H1, 2018 Product Description, Mechanism of Action … (exclusiveherald.com) Human Papillomavirus Associated Diseases Market Pipeline Therapeutics 2018 Drug Description, Target Finding, and … (thefreenewsman.com) Warts Market Therapeutic Pipeline H1, Drugs, Diagnostics, Vaccines and Preventive Technologies (newspublicist.com) Brokerages Anticipate RXi Pharmaceuticals Corp (RXII) to Post -$0.56 Earnings Per Share (americanbankingnews.com)

    Shares of RXi Pharmaceuticals traded down $0.01, hitting $2.24, on Tuesday, MarketBeat Ratings reports. 55,400 shares of the stock were exchanged, compared to its average volume of 275,015. The company has a market capitalization of $9.96 million, a price-to-earnings ratio of -0.53 and a beta of 1.15. RXi Pharmaceuticals has a one year low of $1.90 and a one year high of $7.70.

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Best Undervalued Stocks To Buy For 2019

If youre trying to edge the overall stock market, you can take your chances by picking individual issues, or you could buy an actively managed mutual fund. But some exchange-traded funds may get the job done, too, and it wont cost you much to give them a shot.

Quiz: Test Your Knowledge of ETFs

ETFs are like mutual funds, but they trade like stocks. The biggest and cheapest ETFs mirror major benchmarks, such as Standard & Poors 500-stock index. Annual fees for many ETFs are extraordinarily lowas little as 3 cents per year for every $100 invested.

Yet you dont need to pay much more for ETFs that aim to beat the major bogeys. Such ETFs hold baskets of stocks that often look very different from the S&P 500. Some of these funds focus on shares of undervalued small companies. Others tilt toward stocks with upward share-price momentum, or companies with high-quality balance sheets. You can also buy low volatility ETFs that should hold up relatively well in a market downturn.

Best Undervalued Stocks To Buy For 2019: Virtu Financial, Inc.(VIRT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Extreme Networks, Inc. (NASDAQ: EXTR) fell 26 percent to $8.70 in pre-market trading after the company reported downbeat earnings for its third quarter and issued weak Q4 guidance.
    Caesarstone Ltd. (NASDAQ: CSTE) shares fell 12.5 percent to $16.15 in pre-market trading after the company reported downbeat Q1 results and lowered its FY18 sales forecast.
    MINDBODY, Inc. (NASDAQ: MB) fell 11.7 percent to $38.65 in pre-market trading following mixed Q1 results.
    Vivint Solar, Inc. (NYSE: VSLR) fell 10 percent to $3.60 in pre-market trading after reporting Q1 miss.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares fell 10 percent to $31.63 in pre-market trading after reporting a Q1 earnings miss at 28 cents per share, 5 cents below estimates.
    Monster Beverage Corporation (NASDAQ: MNST) fell 7.7 percent to $49.00 in pre-market trading after reporting downbeat quarterly earnings.
    MaxLinear, Inc. (NYSE: MXL) fell 6.1 percent to $22.39 in pre-market trading following Q1 earnings.
    Virtu Financial, Inc. (NASDAQ: VIRT) fell 5.3 percent to $31.1604 in pre-market trading after announcing a 15 million share common stock secondary offering.
    Papa John's International, Inc. (NASDAQ: PZZA) shares fell 4.7 percent to $56 in pre-market trading after reporting downbeat Q1 earnings

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P
  • [By Joseph Griffin]

    Virtu Financial (NASDAQ: VIRT) is one of 31 publicly-traded companies in the “Security brokers & dealers” industry, but how does it weigh in compared to its competitors? We will compare Virtu Financial to similar companies based on the strength of its earnings, risk, valuation, dividends, profitability, institutional ownership and analyst recommendations.

Best Undervalued Stocks To Buy For 2019: Johnson Outdoors Inc.(JOUT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P

Best Undervalued Stocks To Buy For 2019: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Top 10 Warren Buffett Stocks To Buy For 2018

Hedge-fund billionaire David Tepper joins Warren Buffett on the list of high-profile investors who are bullish on equities. Tepper told CNBC on Monday that he remains optimistic stocks will continue their ascent.

Teppers continued upbeat stance comes despite a record run for the Dow Jones Industrial Average
DJIA, +0.08%
the S&P 500 index
SPX, +0.10%
and the Nasdaq Composite Index
SPX, +0.10%
that has taken the benchmarks to dizzying heights in relatively recent trade, though they were bouncing around in Monday action. Government bonds, notably the 10-year Treasury note
TMUBMUSD10Y, -0.41%
were also drawing bids, lowering yields as prices rose.

Top 10 Warren Buffett Stocks To Buy For 2018: Student Transportation Inc(STB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested shorting small cap school bus transportation services stockStudent Transportation (NASDAQ: STB):

  • [By Monica Gerson]

    Student Transportation Inc (NASDAQ: STB) is estimated to post its quarterly earnings at $0.04 per share on revenue of $167.40 million.

    Exar Corporation (NYSE: EXAR) is projected to post its quarterly earnings at $0.09 per share on revenue of $38.38 million.

Top 10 Warren Buffett Stocks To Buy For 2018: Activision Blizzard, Inc(ATVI)

Advisors’ Opinion:

  • [By Brian Feroldi, Chuck Saletta, Tyler Crowe, Jason Hall, and Jordan Wathen]

    With that in mind, we asked a team of Fools each to highlight a stock that a billionaire investor has been selling recently. Read on to see why they chose Cheniere Energy (NYSEMKT:LNG), Activision Blizzard (NASDAQ:ATVI), Suncor Energy (NYSE:SU), MGIC Investment Corporation (NYSE:MTG), and Extended Stay America (NYSE:STAY).

  • [By Peter Graham]

    In February 2016, King Digital Entertainment PLC (NYSE: KING) was acquired by Activision Blizzard, Inc (NASDAQ: ATVI) for $5.9 billion.

    A technical chart for Glu Mobile shows a November reversal with shares back above a key resistance or support level:

  • [By Peter Graham]

    Note that in February 2016, King Digital Entertainment PLC (NYSE: KING) was acquired by Activision Blizzard, Inc (NASDAQ: ATVI) for $5.9 billion.

    A technical chart for Glu Mobile shows shares breaking and staying above a key resistance/supporting level at the $2.40 level:

Top 10 Warren Buffett Stocks To Buy For 2018: BYD Company Limited (BYDDY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In this video I analyze BYD ltd. (OTCPK:BYDDY) (OTCPK:BYDDF) to see whether it is a great long-term investment opportunity given it is probable that China switches completely to electric vehicles by 2030. I discuss the fundamentals, the margins and where those stand in comparison to Daimler (OTCPK: DDAIF).

  • [By SEEKINGALPHA.COM]

    Some already had their autonomous car bets made with positions in both Tesla and Nvidia (NASDAQ:NVDA) surmising those will be the big winners. They have good company. Trip Chowdhry of Global Equities Research summed up his thesis for autonomous transportation and transportation in general going forward as Winners: Tesla, Nvidia; and Losers: Mobileye (NYSE:MBLY) and all traditional automakers. All traditional automakers? That’s basically every automaker on the planet besides Tesla and maybe Fisker and BYD (OTCPK:BYDDY), that’s a lot of losers. Trip is a talented analyst. I’ve followed him for many years (see his ranking on TipRanks here). Even for him, that’s a pretty bold statement. It got me thinking, is Tesla’s lead in the race for autonomous cars so great that the race is effectively over? I wanted to find out if I was using traditional methodologies too much, overthinking my picks and missing out on the bigger winner, Tesla.

  • [By SEEKINGALPHA.COM]

    BYD Co. (OTCPK:BYDDY) (OTCPK:BYDDF) (HK:1211)

    On December 4, BYD’s CEO Wang presented “The company’s SkyRail electric monorail at the Mayors Summit in Mexico City before 500 guests. This included government officials from over 93 cities, more than 40 mayors, NGO representatives, business leaders, and the media.”

Top 10 Warren Buffett Stocks To Buy For 2018: Laboratory Corporation of America Holdings(LH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Laboratory Corp. of America Holdings (NYSE: LH) is estimated to report its quarterly earnings at $1.96 per share on revenue of $2.19 billion.

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

  • [By Monica Gerson]

    Analysts expect Laboratory Corp. of America Holdings (NYSE: LH) to report its quarterly earnings at $1.96 per share on revenue of $2.19 billion. Laboratory Corp shares rose 0.64 percent to close at $121.77 on Friday.

Top 10 Warren Buffett Stocks To Buy For 2018: T. Rowe Price Group, Inc.(TROW)

Advisors’ Opinion:

  • [By Arie Goren]

    On November 5, Oracle (NYSE:ORCL)confirmed that it has finally completed the acquisition of Netsuite (NYSE:N) for $9.3 billion in cash, or $109 per share that the company had initially offered. In my previous article about Oracle, I had suggested that the acquisition of NetSuite, the cloud business application software company, is a smart move by Oracle. What’s more, it is not paying an excessive price for the deal. In fact, Oracle insisted that it will not pay more than what it had first offered despite the resistance from T Rowe Price (NSDQ:TROW)which demanded $133 per share.

  • [By Jack Delaney]

    Some of the most well-known dividend aristocrats include:

    Exxon Mobil Corp. (NYSE: XOM) pays a dividend of $0.77, which is a yield of 3.75%. Aflac Inc. (NYSE: AFL) pays a dividend of $0.43, which is a yield of 2.32%. AT&T Inc. (NYSE: T) pays a dividend of $0.49, which is a yield of 5.12%. T-Rowe Price Group Inc. (Nasdaq: TROW) pays a dividend of $0.57, which is a yield of 3.27%. Clorox Co. (NYSE: CLX) pays a dividend of $0.84, which is a yield of 2.50%.

    If you just kept the dividends, your investment would be worth $11,147. That’s a difference of only $25. So it may not seem like a big deal at first glance.

Top 10 Warren Buffett Stocks To Buy For 2018: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotech RXi Pharmaceuticals Corp (NASDAQ: RXII) as a long/bullish trade for our short-term portfolio:

Top 10 Warren Buffett Stocks To Buy For 2018: BiondVax Pharmaceuticals Ltd.(BVXV)

Advisors’ Opinion:

  • [By Chris Lange]

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) reported that the scientific journal “Vaccine” published an article citing results from its flu vaccine. The “Vaccine” article, Back to the future: Immunization with M-001, reports that blood plasma samples from people who received M-001 in 2011 (as part of BiondVax’s BVX-005 clinical trial in the elderly) showed significantly increased protective antibodies against the new epidemic 2014/15 flu strain (A/Swiss) – a strain which did not exist when M-001 was administered to the BVX-005 participants.

Top 10 Warren Buffett Stocks To Buy For 2018: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) dropped about 12.3% Wednesday to post a new 52-week low of $12.93 after closing at $14.74 on Tuesday. The stock’s 52-week high is $19.62. Volume of around 2.8 million was nearly 5 times the daily average. The company had no specific news.

Top 10 Warren Buffett Stocks To Buy For 2018: Diageo plc(DEO)

Advisors’ Opinion:

  • [By Mark Fritz]

    Distillers

    Brown-Forman Corporation (NYSE: BF.B): Hold.
    Price Target: $46.00.

    Davide Campari Milano SpA (ADR) (OTC: DVDCY): Buy.
    Price Target: 7.40 euros.

    Diageo plc (ADR) (NYSE: DEO): Hold.
    Price Target: 25.50 pounds.

    PERNOD RICARD EUR1.55 (OTC: PDRDF): Hold.
    Price Target: 98 euros.

    REMY COINTREAU EUR1.60 (OTC: REMYF): Hold.
    Price Target: 99 euros.

    The authors relied on U.S. Census data, industry sources and the National Survey on Drug Use and Health.

  • [By Jayson Derrick]

    Given this less than favorable outlook, the analysts downgrade Diageo plc (ADR) (NYSE: DEO)’s stock rating from Buy to Hold with a price target on the U.K.-listed stock of GBP25.50.

  • [By Leo Sun]

    Retirees should generally invest in companies with wide moats and solid dividends. In a previous article, I noted that AT&T and Unilever were easy-to-understand companies that were ideal for most retirement portfolios. Today, I’ll add two more companies to that list — alcoholic beverage giants Diageo (NYSE:DEO) and Anheuser-Busch InBev (NYSE:BUD).

Top 10 Warren Buffett Stocks To Buy For 2018: Starwood Hotels & Resorts Worldwide, Inc.(HOT)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Monday, cyclical consumer goods & services shares gained by 0.41 percent. Top gainers in the sector included Kandi Technologies Group Inc (NASDAQ: KNDI), Starwood Hotels & Resorts Worldwide Inc (NYSE: HOT), and Lifetime Brands Inc (NASDAQ: LCUT).

  • [By Cameron Saucier]

    After the deal was announced, the stocks of several companies benefited from their current exposure to Cuba or newly announced ties with the island country. For example, Royal Caribbean Cruises (NYSE: RCL) jumped from $69.11 per share on July 1 to $72.99 on July 12. And Starwood Hotels & Resorts Worldwide Inc. (NYSE: HOT) hit its 52-week high of $84.37 in March after it announced new hotel deals in Cuba.